What is she best known for?
The fields of study she is best known for:
Her primary scientific interests are in Sialidase, Biochemistry, NEU1, Ganglioside and Cell biology.
Her specific area of interest is Sialidase, where Taeko Miyagi studies NEU2.
Her NEU2 research is multidisciplinary, relying on both Catabolism and Subcellular localization.
Her biological study focuses on Complementary DNA.
Her biological study deals with issues like Membrane topology, which deal with fields such as Enzyme and Cell–cell interaction.
Taeko Miyagi interconnects Sphingosine, Cell and Cellular differentiation in the investigation of issues within Cell biology.
Her most cited work include:
- Mammalian sialidases: physiological and pathological roles in cellular functions. (237 citations)
- Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression (203 citations)
- Asymmetric membrane ganglioside sialidase activity specifies axonal fate (198 citations)
What are the main themes of her work throughout her whole career to date?
Taeko Miyagi mainly investigates Sialidase, Biochemistry, Sialic acid, Ganglioside and Cell biology.
Her Sialidase research incorporates elements of Molecular biology and Glycoprotein.
Her work in Biochemistry covers topics such as Cancer cell which are related to areas like Signal transduction and Antigen.
Her study looks at the relationship between Sialic acid and fields such as Carcinogenesis, as well as how they intersect with chemical problems.
The concepts of her Ganglioside study are interwoven with issues in Sphingosine, HEXA, Antibody and Stereochemistry.
Her Cell biology research is multidisciplinary, incorporating perspectives in Cell, Cellular differentiation, Membrane and Cell growth.
She most often published in these fields:
- Sialidase (71.54%)
- Biochemistry (46.34%)
- Sialic acid (26.83%)
What were the highlights of her more recent work (between 2013-2021)?
- Sialidase (71.54%)
- Cell biology (20.33%)
- Sialic acid (26.83%)
In recent papers she was focusing on the following fields of study:
Taeko Miyagi focuses on Sialidase, Cell biology, Sialic acid, Biochemistry and NEU1.
NEU2 is the focus of her Sialidase research.
Her studies in NEU2 integrate themes in fields like Protein structure and Binding site.
Taeko Miyagi has included themes like Cell, Cell growth, Gangliosidosis, Catabolism and Membrane associated in her Cell biology study.
Her work carried out in the field of Sialic acid brings together such families of science as Neuraminidase, Neurotrophin, Cell membrane, Cell adhesion and Macrophage.
In her research on the topic of Cancer, Signal transduction is strongly related with Cancer research.
Between 2013 and 2021, her most popular works were:
- Rapid Trimming of Cell Surface Polysialic Acid (PolySia) by Exovesicular Sialidase Triggers Release of Preexisting Surface Neurotrophin (54 citations)
- Structural basis for substrate specificity of mammalian neuraminidases (43 citations)
- Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides. (27 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Sialidase, Sialic acid, Cell biology, Biochemistry and Tumor progression.
Her work deals with themes such as Neurotrophin, Cell membrane, Glycolipid, EGFR inhibitors and Squamous carcinoma, which intersect with Sialidase.
The Sialic acid study combines topics in areas such as Neurotrophic factors, Phospholipase D, Cell migration and Polysialic acid.
Her Cell biology study integrates concerns from other disciplines, such as Cell, Epidermal growth factor, Calmodulin and Gangliosidosis.
Biochemistry and Molecular biology are frequently intertwined in her study.
The various areas that Taeko Miyagi examines in her Tumor progression study include Wnt signaling pathway, LRP6, Phosphorylation, Gene silencing and Colorectal cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
